Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Regulatory News (SIHL)

Share Price Information for Symphony (SIHL)

Share Price is delayed by 15 minutes
Get Live Data
0.35    -0.002 (-0.57%)
Bid:
0.326
Ask:
0.37
Spread: 0.044 (13.497%)
Market Cap: $179.68m
SIHL Live PriceLast checked at - London Stock Exchange

Intraday Symphony Share Chart

Potential Investment

30 Jan 2015 11:00

RNS Number : 6128D
Symphony International Holdings Ltd
30 January 2015
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

30 January 2015

 

Symphony International Holdings Ltd (the "Company" or "Symphony")

Symphony (LSE: SIHL), a leading investor in consumer-related businesses, primarily in the healthcare, hospitality, lifestyle and branded real estate sectors in the Asia-Pacific region, confirms that it is currently in on-going negotiations with SMEC Holdings Limited ("SMEC") in regards to a possible minority investment by the Company in SMEC.

The investment remains subject to the completion of due diligence and agreement on the commercial terms and documentation.

An announcement made by SMEC on 29 January 2015 is reproduced below.

 

SMEC HOLDINGS LIMITED

ACN 057 274 049

NOTICE TO SHAREHOLDERS

HEADS OF AGREEMENT SIGNED WITH A STRATEGIC INVESTOR

 

The Board is pleased to announce that it has signed a non-binding Heads of Agreement (HOA) with Symphony Asia Holdings Pte. Ltd. (SAHPL), which would potentially allow Symphony International Holdings Limited (SIHL) to make a capital investment of A$30 million into SMEC Holdings Limited (SMEC).

 

At the Annual General Meeting in November 2014, the Chairman of the Board, Mr Peter Busbridge, outlined the Groups '2020 Vision' and the funding that would be required to achieve that vision. In short, the 2020 Vision embodies the Board's aspirational goal to achieve annual turnover of $2b by the year 2020. The Boards intention is to use these funds to facilitate acquisitions and organic growth to progress towards the 2020 Vision.

 

The potential investment by SIHL is subject to due diligence, documentation and other conditions precedent which will require further negotiation by the parties, as well as SMEC shareholder approval. SMEC has granted SIHL a period of exclusivity to conclude negotiations and due diligence.

 

The investment initially takes the form of issuing converting preference shares (CPS). These CPS will carry all rights attributable to SMEC Ordinary Shares on a 1:1 basis, other than for winding up and dividends (coupon payment) where they shall have preference.

 

The CPS will be converted to ordinary equity in October 2016 based on a formula which uses the actual EBITDA achieved during the financial years ended 30 June 2015 and 30 June 2016. The number of shares issued will be capped such that SIHL's interest does not exceed 19.9%. In the event the formula results in a number of shares such that SIHL's interest exceeds 19.9%, the excess will be paid by SMEC to SIHL in cash.

 

More detailed information will be provided to shareholders prior to seeking shareholders' approval at an extraordinary general meeting, assuming the transaction proceeds.

 

Cornerstone Investor

 

In addition to achieving the Boards short term funding aims, the SIHL relationship fulfils the Boards desire to secure a 'cornerstone investor' prior to preparing for an Initial Public Offer (IPO).

 

As shareholders will be aware, an IPO has always been part of the Boards strategic aims and forms a large part of the funding strategy that will be required to meet SMEC's 2020 Vision.

 

The Board is confident that the SIHL team fits well with SMEC's culture and that SIHL is generally supportive of the Board's short and longer term strategic aims and objectives.

 

It will be the Board's intention to invite a representative from SIHL to join the Board as an additional Director.

 

Peter Busbridge

Chairman of the Board

SMEC Holdings Limited

29 January 2015

 

 

Background on Symphony International Holdings Limited

Symphony International Holdings Limited (SIHL) is listed on the London Stock Exchange and trades under the ticker symbol: SIHL.

 

SIHL is a sophisticated investment house that provides its investors opportunities to gain exposure to the Asian region's rapidly expanding markets by investing in companies in particular high-growth sectors - primarily healthcare, hospitality, lifestyle and branded real estate - which will benefit from the rising disposable incomes of Asia's increasing, and increasingly aspirational, population.

 

The SIHL business is structured as a 'permanent capital vehicle' which enables it to take longer term investment views. In contrast to traditional private equity funds, SIHL's decisions on investing and divesting are not, therefore, influenced by restricted life-cycles.

 

Typically, SIHL invests in transactions that involve growth capital for later-stage development and expansion, management buy-outs/buy-ins, restructurings and special situations. Where they see a special opportunity, they may also invest a smaller portion of their investment capital in earlier-stage businesses.

 

 

Symphony Asia Limited

Sunil Chandiramani +852 2801 6199

 

 

FTI Consulting

Neil Doyle/ Ed Berry +44 (0) 203 727 1141/1046

 

 

 

About Symphony International Holdings

 

Symphony International Holdings (LSE:SIHL) is a London listed strategic investment company that invests in consumer businesses and develops luxury branded real estate, hospitality and healthcare ventures which are principally in Asia. It offers a way for investors to gain exposure to the rising disposable incomes and wealth in fast growing economies. Symphony's objective is to provide superior capital growth by investing in high quality companies and forming long-term business partnerships with talented entrepreneurs. Symphony is managed by Symphony Investment Managers Limited, which has a team of investment professionals with a broad range of expertise - many of them have been working in Asia for more than 25 years. For more information please visit our website at www.symphonyasia.com.

 

No representation or warranty is made by the Company as to the accuracy or completeness of the information contained in this announcement and no liability will be accepted for any loss arising from its use.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Company in any jurisdiction. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decisions.

 

This announcement is not an offer of securities for sale into the United States. The Company's securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

The Company and the Investment Manager are not associated or affiliated with any other fund managers whose names include "Symphony", including, without limitation, Symphony Financial Partners Co., Ltd.

 

End of Announcement

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGFMGGRGKZM
Date   Source Headline
29th Apr 20262:16 pmRNSResult of AGM
28th Jan 202611:52 amRNSKey Information Document
27th Jan 202610:15 amRNSDirector/PDMR Shareholding
27th Jan 202610:12 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSNet Asset Value(s)
4th Nov 202511:16 amRNSResponse to Shareholder Correspondence
17th Sep 20257:00 amRNSNet Asset Value(s)
17th Sep 20257:00 amRNSInterim Financial Results
26th Jun 20257:00 amRNSNet Asset Value(s)
30th Apr 202512:08 pmRNSResult of AGM
4th Apr 20259:50 amRNSAnnual Financial Report
4th Apr 20259:49 amRNSNotice of AGM
4th Apr 20259:46 amRNSNet Asset Value(s)
5th Feb 202510:38 amRNSDirector/PDMR Shareholding
5th Feb 202510:37 amRNSDirector/PDMR Shareholding
17th Jan 20252:54 pmRNSDirector/PDMR Shareholding
16th Dec 202410:12 amRNSNet Asset Value(s)
27th Sep 20247:00 amRNSNet Asset Value(s)
27th Sep 20247:00 amRNSInterim Financial Results
28th Jun 202411:46 amRNSNet Asset Value(s)
28th Jun 202411:46 amRNSUpdate on Reporting
30th Apr 202410:45 amRNSResult of AGM
5th Apr 20247:00 amRNSAnnual Financial Report
5th Apr 20247:00 amRNSNotice of Annual General Meeting
20th Mar 20246:17 pmRNSNet Asset Value(s)
20th Mar 20247:00 amRNSPreliminary Results
20th Mar 20247:00 amRNSShareholder Update
1st Feb 202411:15 amRNSDirector/PDMR Shareholding
1st Feb 202411:14 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202312:25 pmRNSDirector/PDMR Shareholding
11th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 20237:00 amRNSShareholder Update
16th Nov 20237:00 amRNSKey Information Document
2nd Nov 202311:43 amRNSDirector/PDMR Shareholding
2nd Nov 202311:41 amRNSHolding(s) in Company
1st Nov 20231:27 pmRNSDirector/PDMR Shareholding
1st Nov 20231:26 pmRNSDirector/PDMR Shareholding
26th Oct 202311:15 amRNSDirector/PDMR Shareholding
16th Oct 202311:38 amRNSDirector/PDMR Shareholding
10th Oct 202312:02 pmRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSShareholder Update
26th Sep 20237:00 amRNSInterim Financial Results
25th Sep 202311:27 amRNSStrategy Update
29th Jun 20237:00 amRNSDividend Declaration
19th Jun 20237:00 amRNSNet Asset Value(s)
19th Jun 20237:00 amRNSShareholder Update
15th May 202311:27 amRNSDirector Update
28th Apr 20233:11 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.